A multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones

niversity of Aberdeen0 个研究点目标入组 613 人开始时间: 2013年2月21日最近更新: 2022年4月4日

适应症

试验速览

2017 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/28801422 evaluation of recruitment processes 2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29788982 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33604311/ sub study results (added 22/02/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33810921/ (added 21/02/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35301982/ (added 21/03/2022)

•1. Presence of stone confirmed by Computed Tomography Scan of the Kidneys, Ureters and Bladder (CTKUB)
•2. Patients with a ureteric stone requiring removal
•3. Adults =16 years of age
•4. Single ureteric stone requiring treatment
•5. Suitable for either ESWL or ureteroscopic treatment
•6. Capable of giving written informed consent, which includes adherence with the requirements of the trial.

•1. Pregnancy
•2. Stones not confirmed by CTKUB
•3. Bilateral ureteric stone(s)
•4. Patients with abnormal urinary tract anatomy (such as a horseshoe kidney or ileal conduit)
•5. Patients unable to understand or complete trial documentation

发起方

niversity of Aberdeen